Clinical Trials List
Protocol Number060-CL-603
2013-01-01 - 2013-12-31
Phase IV
Terminated1
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 朱恆成 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
